1. Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
by Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, Sandeep Jain, Amer Assal, Jan Cerny, Edward A. Copelan, Andrew Daly, Zachariah DeFilipp, Shahinaz M. Gadalla, Robert Peter Gale, Siddhartha Ganguly, Betty K. Hamilton, Gerhard Carl Hildebrandt, Jack W. Hsu, Yoshihiro Inamoto, Abraham S. Kanate, H. Jean Khoury, Hillard M. Lazarus, Mark R. Litzow, Sunita Nathan, Richard F. Olsson, Attaphol Pawarode, Olle Ringden, Jacob M. Rowe, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sachiko Seo, Nirav N. Shah, Melhem Solh, Robert K. Stuart, Celalettin Ustun, Ann E. Woolfrey, Jean A. Yared, Edwin P. Alyea, Matt E. Kalaycio, Uday Popat, Ronald M. Sobecks, and Wael Saber
BloodAdv
Volume 2(21):
November 13, 2018
©2018 by American Society of Hematology

2. Saurabh Chhabra et al. Blood Adv 2018;2:2922-2936
©2018 by American Society of Hematology

3. Outcomes after MAC versus RIC alloHCT for CML
Outcomes after MAC versus RIC alloHCT for CML. (A) Adjusted curves for NRM after allo-HCT for CML using MAC vs RIC. (B) Adjusted curves for disease relapse after allo-HCT for CML using MAC vs RIC. (C) Adjusted curves for LFS after allo-HCT for CML using MAC vs RIC. (D) Adjusted curves for OS after allo-HCT for CML using MAC vs RIC.
Outcomes after MAC versus RIC alloHCT for CML. (A) Adjusted curves for NRM after allo-HCT for CML using MAC vs RIC. (B) Adjusted curves for disease relapse after allo-HCT for CML using MAC vs RIC. (C) Adjusted curves for LFS after allo-HCT for CML using MAC vs RIC. (D) Adjusted curves for OS after allo-HCT for CML using MAC vs RIC.
Saurabh Chhabra et al. Blood Adv 2018;2:
©2018 by American Society of Hematology

4. Prespecified subgroup analysis according to baseline characteristics showing HRs and 95% CIs for OS after allo-HCT for CML patients using MAC vs RIC,
Prespecified subgroup analysis according to baseline characteristics showing HRs and 95% CIs for OS after allo-HCT for CML patients using MAC vs RIC,
Saurabh Chhabra et al. Blood Adv 2018;2:
©2018 by American Society of Hematology